login
login

Europe Daily Bulletin No. 7824

19 October 2000
Contents Publication in full By article 53 / 59
ECONOMIC INTERPENETRATION / (eu) biotechnology

The American firm CORIXA (stock market evaluation of $930 million with a $25 million turnover in 1999) intends making a friendly bid for its compatriot COULTER PHARMACEUTICAL (losses of $50.6 million in 1999).

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION